21 CFR Part 820 Subpart 0 – Statistical Techniques
Description:
By the end of this course you will have learned, how each manufacturer shall establish and maintain procedures for identifying valid statistical techniques required for establishing, controlling, and verifying the acceptability of process capability and product characteristics and how when sampling plans, when used, shall be written and based on a valid statistical rationale.
Curriculum for this course:
Introduction
Overview | 1 mins 10 secs |
ISO, ICH and the FDA | 1 min 30 secs |
Program organization | 1 min 25 secs |
Program objectives | 1 min 50 secs |
Definition of a medical device | 1 mins 11 secs |
Class I, II and III | 1 mins 33 secs |
Intended use | 1 mins 10 secs |
History of 21 CFR Part 820
21 CFR 820 Timeline | 1 min 50 secs |
1906 – The Jungle | 1 min 45 secs |
1937 – Massengil Company | 1 min 10 secs |
1957 – Thalidomide | 58 secs |
1971 – Dalcon Corporation | 1 min 48 secs |
1990 – FDA device recall report | 1 min 24 secs |
A regulatory evolution | 1 min 30 secs |
Subpart O – Statistical Techniques
Course Introduction | 1 min 20 secs |
Learning Objectives | 56 secs |
Introduction | 1 min 31 secs |
Statistical Analysis | 1 min 39 secs |
Data Normality | 1 min 10 secs |
Data Normality – Statistical Tests | 1 min 48 secs |
Outliers | 1 mins 23 secs |
Outliers – Variability | 1 mins 31 secs |
Process Capability | 1 mins 41 secs |
Process Capability and Process Capability Index | 1 min 01 secs |
Process Capability Index and Process Performance Index | 58 secs |
The CpK | 50 secs |
Gage R&R | 1 min 09 secs |
Conclusion
Final Exam
Certification
Talk to us
Find out how we can help you bring your life science training to the next level.